These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5891500)

  • 1. [Pharmacological research in the diphenylcarbamic acid thio ester series. II].
    Wirth W; Gösswald R
    Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):393-417. PubMed ID: 5891500
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)].
    Hoffmeister F; Wuttke W; Kroneberg G
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems in transferring data from animals to man in behavioral teratology].
    Pavlík A; Jelínek R; Benesová O
    Cas Lek Cesk; 1982 Sep; 121(37):1157-60. PubMed ID: 7139673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological effects of clonazepam, an anticonvulsant, on the central nervous system].
    Yajima T; Uritani K; Aoki R; Suzuki T; Nakamura K
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):763-94. PubMed ID: 1035184
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties.
    Chiba S; Saji Y; Hibino H; Takeo Y; Yui T
    Arzneimittelforschung; 1968 Mar; 18(3):303-9. PubMed ID: 4386816
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological study of piroheptine, a new antiparkinson drug. II. Anticholinergic, antihistaminic, and psychopharmacological actions and toxicity.
    Hitomi M; Watanabe N; Kumadaki N; Kumada S
    Arzneimittelforschung; 1972 Jun; 22(6):961-6. PubMed ID: 4403219
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
    Lish PM; Weikel JH; Dungan KW
    J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the central and peripheral pharmacological properties of 1-(2 dimethylaminoethyl)-1-phenylidene].
    Buchel L; Levy J
    Therapie; 1968; 23(5):1135-46. PubMed ID: 4387506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 11. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spasmolytic and cholinergic blocking properties and toxicity of levomepate, 1-tropine alpha-methyltropate.
    Bianchi G; Dezulian MV; Kramer M; Maffii G; Quinton RM; Serralunga MG
    Toxicol Appl Pharmacol; 1967 May; 10(3):424-43. PubMed ID: 6059662
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug toxicity in the animal fetus.
    McColl JD
    Appl Ther; 1967 Nov; 9(11):915-7. PubMed ID: 4964963
    [No Abstract]   [Full Text] [Related]  

  • 14. [The content of gamma-aminobutyric acid in the brain of animals in the case of stimulation or inhibition of the central nervous system].
    Maslova MN
    Dokl Akad Nauk SSSR; 1965 Sep; 164(1):230-3. PubMed ID: 5872993
    [No Abstract]   [Full Text] [Related]  

  • 15. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the pharmacological effect of oxyphenamate].
    Gorshkova VK; Mikhaĭlova TV; Gilev AP
    Farmakol Toksikol; 1970; 33(3):264-7. PubMed ID: 5465696
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action.
    Lish PM; Labudde JA; Peters EL; Robbins SI
    Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):467-88. PubMed ID: 4380481
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interference of the central antichloinergic effect in experimental animal tests of potential antidepressives].
    Schaumann W; Ribbentrop A
    Arzneimittelforschung; 1966 May; 16(5):646-9. PubMed ID: 6014433
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological studies on 5-hydroxy-L-tryptophan (L-5HTP). 1. Influence of L-5HTP on the central nervous system].
    Omori K; Orima H; Kojima T; Takahira H
    Nihon Yakurigaku Zasshi; 1973 Jul; 69(4):523-41. PubMed ID: 4546003
    [No Abstract]   [Full Text] [Related]  

  • 20. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.